Future Market Insights is of the opinion that the antibody conjugation kits market will be characterized by formulation and platform leaders that can industrialize precision conjugation into a repeatable, compliance-ready workflow. The category is progressing away from chemical labeling toward engineered conjugation platforms that enable precise molecular positioning, consistent drug-to-antibody ratios, and workflow automation readiness.